Startseite
English
Erweiterte Suche
Durchblättern nach ...
Publikationen im Überblick
Ansprechpartner
Hilfe
DOI
 |
|
möglich sobald bei der ZB eingereicht worden ist.
Aptamer-based targeted drug delivery systems.
Nanotechnology in the Life Sciences, 93-122 (2022)
Nano-therapeutics often aims to design site-specific delivery of the therapeutics at the molecular level to treat diseased tissues or organs. On the contrary, both reachability and interaction of these therapeutic active molecules at the delivery site are challenging tasks, and most of the therapeutics are unable to achieve therapeutic efficacy, because of their side effect associated with off-targeting due to limited selectivity. Therefore, to avoid “off-target” delivery, presently aptamer-based drug target delivery systems have emerged as a vital therapeutic option having specific receptor recognition ability. Moreover, the wide range of chemical flexibility and tissue penetration competency of such delivery systems make aptamers suitable candidates for targeted drug delivery. Recently, various cutting-edge aptamer-based technologies received considerable attention due to their wider applicability in therapeutics including chemotherapeutics, peptides, toxins, and oligonucleotides. The objective of this book chapter is to explore aptamer-based targeting strategy as an advanced therapeutic option supported by evidence collected from past and current research progress. The outcome of the current chapter is thoroughly evaluated, discussed, and concluded for the present scenario and future direction considering the aptamer-based drug delivery.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Aptamers ; Dna Aptamer ; Drug Delivery ; Molecular Specificity ; Molecular Target ; Proteins
ISSN (print) / ISBN
2523-8027
e-ISSN
2523-8035
Bandtitel
Pharmaceutical Nanobiotechnology for Targeted Therapy
Zeitschrift
Nanotechnology in the Life Sciences
Quellenangaben
Seiten: 93-122
Verlag
Springer
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Lung Health and Immunity (LHI)